Maravai LifeSciences Holdings, Inc. MRVI Corporate — Asset Impairments
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s corporate — asset impairments.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s corporate — asset impairments?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported corporate — asset impairments of $0 in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s corporate — asset impairments changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s corporate — asset impairments decreased by 100.0% year-over-year, from $963.75K to $0.
- What does corporate — asset impairments mean?
- Reflects non-cash charges recognized when the carrying value of corporate assets exceeds their fair market value. This metric indicates a decline in the expected economic benefit of long-term assets, such as goodwill, intangible assets, or property. It serves as a key indicator of potential strategic misalignments or deteriorating asset performance.